These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8680269)

  • 1. High-risk coronary angioplasty assisted by active hemoperfusion. A feasibility study.
    Angelini P; Hernandez C; Ferguson JJ; Leachman RD; Garcia-Gregory JA; Benrey J; Schnee MJ; Fighali SF; Krajcer Z
    Tex Heart Inst J; 1996; 23(1):15-23. PubMed ID: 8680269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
    Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
    J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous transluminal coronary angioplasty failures in patients with multivessel disease. Is there an increased risk?
    Wang N; Gundry SR; Van Arsdell G; Razzouk AJ; Hill AC; Sjolander M; Cavazos KA; Brewer JM; Vyhmeister EE; Bailey LL
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):214-21; discussion 221-3. PubMed ID: 7609545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5.
    Henriques JP; Remmelink M; Baan J; van der Schaaf RJ; Vis MM; Koch KT; Scholten EW; de Mol BA; Tijssen JG; Piek JJ; de Winter RJ
    Am J Cardiol; 2006 Apr; 97(7):990-2. PubMed ID: 16563902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-center experience with the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention.
    Al-Husami W; Yturralde F; Mohanty G; Pastore C; Lotun K; Venesy D; Waxman S; Pyne C; Gossman D; Nesto R; Piemonte T
    J Invasive Cardiol; 2008 Jun; 20(6):319-22. PubMed ID: 18523330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the perfusion balloon as a primary dilation device.
    Phillips HR; Ohman EM; Labinaz M; Sketch MH; Stack R
    J Invasive Cardiol; 1995; 7 Suppl B():17B-24B; discussion 50B-56B. PubMed ID: 10155119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of cardiac survival after percutaneous transluminal coronary angioplasty in patients with severe left ventricular dysfunction.
    Serota H; Deligonul U; Lee WH; Aguirre F; Kern MJ; Taussig SA; Vandormael MG
    Am J Cardiol; 1991 Feb; 67(5):367-72. PubMed ID: 1994660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk coronary angioplasty using percutaneous cardiopulmonary bypass support.
    Kaul U; Sharma M; Bahl VK; Dev V; Wasir HS; Venugopal P
    Natl Med J India; 1992; 5(5):206-10. PubMed ID: 1302578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary and circulatory support strategies for percutaneous transluminal coronary angioplasty in high-risk patients.
    Leung WH
    Am Heart J; 1993 Jun; 125(6):1727-38. PubMed ID: 8498317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry.
    Sjauw KD; Konorza T; Erbel R; Danna PL; Viecca M; Minden HH; Butter C; Engstrøm T; Hassager C; Machado FP; Pedrazzini G; Wagner DR; Schamberger R; Kerber S; Mathey DG; Schofer J; Engström AE; Henriques JP
    J Am Coll Cardiol; 2009 Dec; 54(25):2430-4. PubMed ID: 20082934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study.
    Burzotta F; Paloscia L; Trani C; Mascellanti M; Mongiardo R; Materazzo G; Niccoli G; Di Marco M; Leone AM; Porto I; Mazzari MA; Rebuzzi AG; Schiavoni G; Crea F
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1004-10. PubMed ID: 18799962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous support devices for high risk or complicated coronary angioplasty.
    Lincoff AM; Popma JJ; Ellis SG; Vogel RA; Topol EJ
    J Am Coll Cardiol; 1991 Mar; 17(3):770-80. PubMed ID: 1993799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial and long-term results of coronary angioplasty: a report from King Chulalongkorn Memorial Hospital.
    Ngamtrairai P; Srimahachota S; Boonyaratavej S; Udayachalerm W; Chaipromprasit C; Chayanont D; Somabutr C; Ngarmukos P
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S62-9. PubMed ID: 12188453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole: hemodynamic, contractile and dynamic ventricular consequences].
    Strauer BE; Heidland UE; Heintzen MP; Schwartzkopff B
    Z Kardiol; 1995 Nov; 84(11):898-910. PubMed ID: 8571641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "High-risk" percutaneous transluminal coronary angioplasty with preventive intra-aortic balloon counterpulsation.
    Voudris V; Marco J; Morice MC; Fajadet J; Royer T
    Cathet Cardiovasc Diagn; 1990 Mar; 19(3):160-4. PubMed ID: 2317854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary angioplasty in high risk patients with percutaneous cardiopulmonary support.
    Sivananthan MU; Rees MR; Browne TF; Verma SP; Hick DG; Whittaker S; Davies GA; Tan LB
    Eur Heart J; 1994 Aug; 15(8):1057-62. PubMed ID: 7988596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional flow adjusted hemoperfusion during coronary angioplasty: circulatory support/myocardial protection.
    Overlie PA
    J Interv Cardiol; 1995 Jun; 8(3):257-63. PubMed ID: 10155237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous cardiopulmonary bypass support in high-risk patients undergoing percutaneous transluminal coronary angioplasty.
    Shawl FA; Domanski MJ; Punja S; Hernandez TJ
    Am J Cardiol; 1989 Dec; 64(19):1258-63. PubMed ID: 2589189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic support with a percutaneous left ventricular assist device during stenting of an unprotected left main coronary artery.
    Kar B; Butkevich A; Civitello AB; Nawar MA; Walton B; Messner GN; Gregoric ID; Feldman J; Myers TJ; Gemmato C; Delgado RM
    Tex Heart Inst J; 2004; 31(1):84-6. PubMed ID: 15061632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved survival for stenting vs. balloon angioplasty for the treatment of coronary artery disease in patients with ischemic left ventricular dysfunction.
    Lipinski MJ; Martin RE; Cowley MJ; Goudreau E; Malloy WN; Vetrovec GW
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):547-53. PubMed ID: 16216018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.